Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,489
datasets available to search
ShareScore release 0.9.0
Dataset results
2,489 results for “Sars-CoV-2”
SARS-COV-2 Detection From Used Surgical Mask
ClinicalTrials.gov study NCT06027398. IPD Sharing: YES. Countries: 1. Publications: 4.
Study of a Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine
ClinicalTrials.gov study NCT04962893. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Specific miRNA Encoded by SARS-CoV-2 as a Diagnostic Tool to Predict Disease Severity in COVID-19 Patients
ClinicalTrials.gov study NCT05739513. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant
ClinicalTrials.gov study NCT04368988. IPD Sharing: NO. Countries: 2. Publications: 8.
Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)
ClinicalTrials.gov study NCT05904054. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2
ClinicalTrials.gov study NCT04318314. IPD Sharing: YES. Countries: 1. Publications: 5.
Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)
ClinicalTrials.gov study NCT04556318. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19)
ClinicalTrials.gov study NCT04322123. IPD Sharing: NO. Countries: 1. Publications: 2.
COVID-19: Nasal and Salivary Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses
ClinicalTrials.gov study NCT04352959. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19)
ClinicalTrials.gov study NCT04320056. IPD Sharing: NO. Countries: 1. Publications: 54.
Markers of Severity (CD177,S100A8 &S100A12) in Sever Acute Respiratory Syndrome Coronavirus 2(SARS-COV-2) Patients
ClinicalTrials.gov study NCT05201625. IPD Sharing: YES. Countries: 1. Publications: 4.
SARS-CoV-2 Infection Among Healthcare Workers
ClinicalTrials.gov study NCT05680896. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Screening of Health-care Workers in an University Hospital for SARS-CoV-2
ClinicalTrials.gov study NCT04567836. IPD Sharing: NO. Countries: 1. Publications: 4.
Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva
ClinicalTrials.gov study NCT04578509. IPD Sharing: NO. Countries: 1. Publications: 17.
Risk of Infection of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), COVID-19, in a Massive Musical Show With Transmission Prevention Measures
ClinicalTrials.gov study NCT04668625. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prognostic Impact of the Nutritional Status of Individuals Aged 70 Years and Older With SARS-CoV-2
ClinicalTrials.gov study NCT04672343. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Inf
ClinicalTrials.gov study NCT06684379. IPD Sharing: NO. Countries: 1. Publications: 3.
Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early
ClinicalTrials.gov study NCT04885452. IPD Sharing: NO. Countries: 1. Publications: 4.
Systematic Assessment of SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill Patients, and Patients Who Died From COVID-19
ClinicalTrials.gov study NCT04472013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase III Clinical Study of a SARS-CoV-2 Messenger Ribonucleic Acid (mRNA) Vaccine Candidate Against COVID-19 in Population Aged 18 Years and Above
ClinicalTrials.gov study NCT04847102. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.